Evidence map›Paper›PMID 33780476›Full record

ArticlePloS one2021

Three step flow focusing enables image-based discrimination and sorting of late stage 1 Haematococcus pluvialis cells.

Daniel Kraus, Andreas Kleiber, Enrico Ehrhardt, Matthias Leifheit, Peter Horbert, Matthias Urban, Nils Gleichmann, Günter Mayer, Jürgen Popp, Thomas Henkel

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel KrausLeibniz Institute of Photonic Technology, Jena, Germany.ORCID 0000-0001-7539-5260
Andreas KleiberLeibniz Institute of Photonic Technology, Jena, Germany.
Enrico EhrhardtGesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e. V. (GMBU), Halle (Saale), Germany.
Matthias LeifheitGesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e. V. (GMBU), Halle (Saale), Germany.
Peter HorbertLeibniz Institute of Photonic Technology, Jena, Germany.
Matthias UrbanLeibniz Institute of Photonic Technology, Jena, Germany.
Nils GleichmannLeibniz Institute of Photonic Technology, Jena, Germany.
Günter MayerLeibniz Institute of Photonic Technology, Jena, Germany.
Jürgen PoppLeibniz Institute of Photonic Technology, Jena, Germany.
Thomas HenkelLeibniz Institute of Photonic Technology, Jena, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Label-free and gentle separation of cell stages with desired target properties from mixed stage populations are a major research task in modern biotechnological cultivation process and optimization of micro algae. The reported microfluidic sorter system (MSS) allows the subsequent investigation of separated subpopulations. The implementation of a viability preserving MSS is shown for separation of late stage 1 Haematococcus pluvialis (HP) cells form a mixed stage population. The MSS combines a three-step flow focusing unit for aligning the cells in single file transportation mode at the center of the microfluidic channel with a pure hydrodynamic sorter structure for cell sorting. Lateral displacement of the cells into one of the two outlet channels is generated by piezo-actuated pump chambers. In-line decision making for sorting is based on a user-definable set of image features and properties. The reported MSS significantly increased the purity of target cells in the sorted population (94%) in comparison to the initial mixed stage population (19%).

Indexed as

Flow CytometryCell SeparationChlorophyceaeChlorophytaMicrofluidic Analytical TechniquesMicrofluidics

Identifiers

PMID33780476
PMCPMC8007022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.